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Supporting Information 
General Information.  Commercial reagents were purified prior to use following the 
guidelines of Perrin and Armarego.1 All solvents were purified according to the method 
of Grubbs. 2   All aldehydes were purified by either distillation or silica gel 
chromatography prior to use. Starting silyl enolethers were prepared according to the 
literature from corresponding ketones and purified by distillation prior to use. 3  
Organic solutions were concentrated under reduced pressure on a Büchi rotary 
evaporator using an ice-water bath for volatile compounds.  Chromatographic 
purification of products was accomplished using forced-flow chromatography on ICN 
60 32-64 mesh silica gel 63 according to the method of Still4 and where noted, Davisil 
S-743-1 and Iatrobeads® 6RS-8060 were used in place of silica gel.  Thin-layer 
chromatography (TLC) was performed on EM Reagents 0.25 mm silica gel 60-F plates.  
                                                      
1 Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals; 3rd ed., Pergamon 
Press, Oxford, 1988. 
2 Pangborn, A. B.; Giardello, M. A.; Grubbs, R. H.; Rosen, R. K.; Timmers, F. J. 
Organometallics 1996, 15, 1518. 
3 Moriarty, R.; Prakash, O.; Duncan, M. P. J. Chem. Soc., Perkin Trans. 1, 1987, 559; Drewes, S. 
E.; Hogan, C. J.; Kaye, P. T.; Roos, G. H. P. J. Chem. Soc., Perkin Trans. 1, 1989, 1585; 
Kozmin, S. A.; Rawal, V. H. J. Org. Chem. 1997, 62, 5252. 
4 Still, W. C.; Kahn, M.; Mitra, A. J. J. Org. Chem. 1978, 43, 2923. 
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Visualization of the developed chromatogram was performed by fluorescence 
quenching or by staining using either KMnO4 or p-anisaldehyde stains. 
1H and 13C NMR spectra were recorded on a Varian Mercury 300 (300 MHz or 
75 MHz), and are internally referenced to residual protio solvent signals.  Data for 1H 
NMR are reported as follows: chemical shift (δ ppm), multiplicity (s = singlet, d = 
doublet, t = triplet, q = quartet, m = multiplet), integration, coupling constant (Hz) and 
assignment.  Data for 13C NMR are reported in terms of chemical shift.  IR spectra 
were recorded on a Perkin Elmer Paragon 1000 spectrometer and are reported in terms 
of frequency of absorption (cm-1).  Mass spectra were obtained from the California 
Institute of Technology Mass Spectral facility by electron ionization, chemical 
ionization, or fast atom/ion bombardment techniques.  Gas liquid chromatography 
(GLC) was performed on Hewlett-Packard 6850 and 6890 Series gas chromatographs 
equipped with a split-mode capillary injection system and flame ionization detectors 
using a Varian CP-Chirasil-Dex-CB (30 m × 0.25 mm) column as noted.  Supercritical 
fluid chromatography (SFC) was performed on a Berger Minigram equipped with a 
variable-wavelength UV detector using a Chiralcel AD-H column (25 cm × 0.46 cm) 
and AD guard (5 cm × 0.46 cm) or Chiralcel OJ-H column (25 cm × 0.46 cm) and OJ 
guard (5 cm × 0.46 cm) as noted.  Optical rotations were measured on a Jasco P-1010 
polarimeter, and [α]D values are reported in 10-1 dg cm2 g-1; concentration (c) is in g/100 
ml. 
 
General procedure for enantioselective α-enolation of aldehydes (Table 1):  
A solution of the trifluoromethanesulfonic acid salt of (2S, 5S)-2-tert-butyl-5-benzyl-3-
methylimidazolidin-4-one (20 mol%) in acetone (0.0625 M) is prepared in a 
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scintillation vial equipped with a magnetic stir bar at -78 oC under argon.  In this order, 
the aldehyde (1.0 eq), trimethyl-(1-phenyl-vinyloxy)-silane (2.0 eq), water (2.0 eq), 
CAN (2.0 eq), and 2,6-di-tert-butyl pyridine (2.0 eq) are added to this mixture. After 
purging the solution with argon for 1 minute, this mixture is warmed to -20 oC and 
stirred at constant temperature for 24 hours until no further reaction progression is 
observed. The cold reaction is poured into diethyl ether and filtered through davisil, 
washed with ether and concentrated in vacuo. The resulting residue is purified by 
column chromatography to provide the title compounds.  
 
H
O
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O  
(R)-2-(2-oxo-2-phenyl ethyl) octanal (Table 1, entry 1):  Prepared according 
to the general procedure from octanal (32.8 mg, 0.256 mmol) to provide the title 
compound as a colorless oil (52 mg, 85% yield, 90% ee) after purification by flash 
column chromatography on Davisil (3% ether/pentane).  The enantiomeric ratio was 
determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) column (5% to 9.5% 
CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); tr = 1.95 min and 2.12 
min.  IR (film) 2928, 2857, 1726, 1685, 1449, 1224 cm-1; 1H NMR (300 MHz, CDCl3) 
δ 9.83 (s, 1H, CHO), 8.00-7.96 (m, 2H, aryl H), 7.60-7.55 (m, 1H, aryl H), 7.50-7.44 
(m, 2H, aryl H), 3.48 (dd, 1H, J = 7.65, 17.55 Hz, CH2COPh), 3.15-2.99 (m, 2H, 
CH2COPh & CHCHO), 1.86-1.74 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.58-1.48 (m, 1H, 
CH2CH2CH2CH2CH2CH3), 1.41-1.25 (m, 8H, CH2CH2CH2CH2CH2CH3), 0.88 (t, 3H, 
CH3);  13C NMR (75 MHz, CDCl3) δ 203.66, 198.03, 136.55, 133.28, 128.62, 128.07, 
46.73, 37.62, 31.57, 29.32, 28.85, 27.05, 22.54, 14.03; HRMS (EI+) exact mass 
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calculated for [M]+ (C16H22O2) requires m/z 246.1620, found m/z 246.1618; [α]D= +63.9 
(c = 1.30, CHCl3).  
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(R)-2-(2-oxo-2-phenyl ethyl)-undec-10-enal (Table 1, entry 2):  Prepared 
according to the general procedure from 10-undecenal (43 mg, 0.256 mmol) to provide 
the title compound as a colorless oil (68 mg, 92% yield, 92% ee) after purification by 
flash column chromatography on Davisil (3% ether/pentane).  The enantiomeric ratio 
was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) column (5% to 
9.5% CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); tr = 2.66 min 
and 2.90 min.  IR (film) 3583, 2927, 2855, 1726, 1685, 1449 cm-1; 1H NMR (300 
MHz, CDCl3) δ 9.82 (bs, 1H, CHO), 7.99-7.95 (m, 2H, aryl H), 7.60-7.54 (m, 1H, aryl 
H), 7.49-7.44 (m, 2H, aryl H), 5.80 (m, 1H, CH=CH2), 5.02-4.90 (m, 2H, CH=CH2), 
3.47 (dd, 1H, J = 7.5, 17.4 Hz, CH2COPh), 3.14-2.98 (m, 2H, CH2COPh & CHCHO), 
2.03 (dt, 2H, J = 7.0, CH2CH=CH2), 1.79 (m, 1H, CH2CHCHO), 1.53 (m, 1H, 
CH2CHCHO), 1.36-1.30 (m, 10H);  13C NMR (75 MHz, CDCl3) δ 203.58, 197.96, 
139.04, 136.51, 133.25, 128.58, 128.04, 114.17, 46.69, 37.60, 33.69, 29.56, 29.17, 
28.93, 28.79, 27.03; HRMS (EI+) exact mass calculated for [M]+ (C19H26O2) requires m/z 
286.1933, found m/z 286.1920; [α]D= +56.5 (c = 0.66, CHCl3). 
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J. Am. Chem. Soc. Supporting Information S5 
(R)-2-cyclohexyl-4-oxo-4-phenyl butyraldehyde (Table 1, entry 3):  
Prepared according to the general procedure from cyclohexylacetaldehyde (32.3 mg, 
0.256 mmol) to provide the title compound as an white solid (46 mg, 74% yield, 93% 
ee) after purification by flash column chromatography on Davisil (3% ether/pentane).  
The enantiomeric ratio was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 
cm) column (5% to 9.5% CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 
mL/min); tr = 2.56 min and 2.77 min.  IR (film) 2925, 2852, 2342, 2361, 1723, 1684, 
1449 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.87 (s, 1H, CHO), 7.99-7.96 (m, 2H, aryl H), 
7.60-7.43 (m, 3H, aryl H), 3.53 (dd, 1H, J = 9.15, 17.85 Hz, CH2COPh), 3.11 (m, 1H, 
CHCHO), 2.94 (dd, 1H, J = 3.60, 18.00 Hz, CH2COPh), 1.94-1.64 (m, 6H, cyclohexyl), 
1.38-1.07 (m, 5H, cyclohexyl);  13C NMR (75 MHz, CDCl3) δ 203.96, 198.33, 136.65, 
133.16, 128.55, 128.04, 52.14, 38.04, 34.74, 31.03, 30.10, 26.42, 26.10; HRMS (FAB+) 
exact mass calculated for [M]+ (C16H21O2) requires m/z 245.1542, found m/z 245.1545; 
[α]D= +105.4 (c = 0.46, CHCl3).  
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(R)-2-Benzyl-4-oxo-4-phenyl-butyraldehyde (Table 1, entry 4):  Prepared 
according to the general procedure from hydrocinnamaldehyde (34.4 mg, 0.256 mmol) 
to provide the title compound as a colorless oil (50 mg, 77% yield, 91% ee) after 
purification by flash column chromatography on Davisil (7% ether/pentane).  The 
enantiomeric ratio was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) 
column (5% to 9.5% CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); 
tr = 4.59 min and 5.02 min.  IR (film) 3583, 1723, 1682, 1598, 1580, 1449, 1361, 1228 
J. Am. Chem. Soc. Supporting Information S6 
cm-1; 1H NMR (300 MHz, CDCl3) δ 9.90 (brs, 1H, CHO), 7.92-7.89 (m, 2H, aryl H), 
7.59-7.54 (m, 1H, aryl H), 7.47-7.42 (m, 2H, aryl H),  7.33-7.19 (m, 5H), 3.47-3.35 
(m, 2H), 3.21-3.14 (m, 1H), 3.06- 2.97 (m, 1H), 2.86-2.79 (m, 1H);  13C NMR (75 
MHz, CDCl3) δ 202.99, 197.81, 138.07, 136.37, 133.32, 129.00, 128.72, 128.58, 
128.03, 126.70, 48.32, 37.21, 34.68; HRMS (EI+) exact mass calculated for [M]+ 
(C17H16O2) requires m/z 252.1150, found m/z 252.1148; [α]D= +25.4 (c = 0.55, CHCl3).  
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(R)-5-Benzyloxy-2-(2-oxo-2-phenylethyl)-pentanal (Table 1, entry 5):  
Prepared according to the general procedure from 5-(benzyloxy)pentanal (49 mg, 0.256 
mmol) to provide the title compound as a colorless oil (56 mg, 71% yield, 90% ee) after 
purification by flash column chromatography on Davisil (20% ether/pentane).  The 
enantiomeric ratio was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) 
column (5% to 50% CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); tr 
= 5.60 min and 6.18 min.  IR (film) 2930, 2858, 2361, 2342, 1724, 1684, 1449, 1361, 
1221, 1102 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.82 (bs, 1H, CHO), 7.99-7.95 (m, 2H, 
aryl H), 7.61-7.55 (m, 1H, aryl H), 7.49-7.44 (m, 2H, aryl H), 7.38-7.26 (m, 5H, aryl 
H), 4.50 (s, 2H, OCH2Ph), 3.53 -3.44 (m, 3H, CH2COPh & CH2OBn), 3.16-3.01 (m, 
2H, CH2COPh & CHCHO), 1.97-1.87 (m, 1H, CH2CH2CH2OBn), 1.76-1.62 (3H, m, 
CH2CH2CH2OBn);  13C NMR (75 MHz, CDCl3) δ 203.34, 197.83, 138.26, 136.42, 
133.30, 128.60, 128.36, 128.05, 127.62, 127.59, 72.96, 69.71, 46.36, 37.64, 27.24, 
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25.55; HRMS (EI+) exact mass calculated for [M]+ (C20H22O3) requires m/z 310.1569, 
found m/z 310.1562; [α]D= +44.3 (c = 0.55, CHCl3). 
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(R)-4-(1-Formyl-3-oxo-phenyl propyl)-piperidine-1-carboxylic acid tert-
butyl ester (Table 1, entry 6):  Prepared according to the general procedure from tert-
butyl 4-(formylmethyl)piperidine-1-carboxlate (58 mg, 0.256 mmol) to provide the title 
compound as an white solid (75 mg, 84% yield, 95% ee) after purification by flash 
column chromatography on Davisil (25% ether/pentane).  The enantiomeric ratio was 
determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) column (5% to 50% 
CH3CN, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); tr = 3.65 min and 4.20 
min.  IR (film) 2975, 2930, 2854, 1720, 1686, 1449, 1424, 1365, 1168 cm-1; 1H NMR 
(300 MHz, CDCl3) δ 9.87 (d, 1H, J = 0.6 Hz, CHO), 7.98-7.95 (m, 2H, aryl H), 7.61-
7.55 (m, 1H, aryl H), 7.50-7.44 (m, 2H, aryl H),  4.15 (brs, 2H, CH2NBoc), 3.52 (dd, 
1H, J = 8.70, 18.0 Hz, CH2COPh), 3.14 (m, 1H, CHCHO), 2.99 (dd, 1H, J = 3.75, 17.9 
Hz, CH2COPh), 2.68 (m, 2H, CH2NBoc), 2.03 (m, 1H, CHcyclohexyl),  1.73-1.57 (m, 
2H, CH2CH2NBoc), 1.44 (s, 9H, tBu), 1.42-1.31 (m, 2H, CH2CH2NBoc);  13C NMR 
(75 MHz, CDCl3) δ 203.06, 197.77, 154.58, 136.32, 133.37, 128.61, 128.02, 79.55, 
51.11, 36.19, 34.78, 29.94, 28.98, 28.36; HRMS (EI+) exact mass calculated for [M]+ 
(C20H28NO4) requires m/z 346.2018, found m/z 346.2008; [α]D= +45.3 (c = 0.5, CHCl3).  
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General procedure for enantioselective α-enolation of octanal with various 
silyl enolethers (Table 2):  A solution of the trifluoromethanesulfonic acid salt of (2S, 
5S)-2-tert-butyl-5-benzyl-3-methylimidazolidin-4-one (20 mol%) in DME (0.25 M) is 
prepared in a scintillation vial equipped with a magnetic stir bar at -78 oC under argon.  
In this order, octanal (1.0 eq), silyl enolether (1.5 or 2.0 eq as noted), water (2.0 eq), 
CAN (2.0 eq), and 2,6-di-tert-butyl pyridine (2.0 eq) are added to this mixture. After 
purging the solution with argon for 1 minute, this mixture is warmed to -20 oC and 
stirred at constant temperature for 24 hours until no further reaction progression is 
observed. The cold reaction is poured into diethyl ether and filtered through davisil, 
washed with ether and concentrated in vacuo. The resulting residue is purified by 
column chromatography to provide the title compounds. 
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(R)-2-(2-(furan-2-yl)-2-oxoethyl)octanal (Table 2, entry 2):  Prepared 
according to the general procedure from octanal (32.8 mg, 0.256 mmol) and tert-
butyl(1-(furan-2-yl)vinyloxy)dimethylsilane (86.2 mg, 0.384 mmol) at -50 oC reaction 
temperature to provide the title compound as a colorless oil (46.6 mg, 77% yield, 92% 
ee) after purification by flash column chromatography on Davisil (3% ether/pentane).  
The enantiomeric ratio was determined by SFC analysis Chiralcel AD-H (25 cm × 0.46 
cm) column (5% to 50% MeOH, linear gradient, 100 bar, 35°C oven, flow = 4.0 
mL/min) after oxidation of product to acid derivative; (S) isomer tr = 3.78 min and (R) 
isomer tr = 4.49 min.  IR (film) 3135, 2929, 2857, 1726, 1677, 1570, 1469, 1397, 1263, 
1164, 1084, 1018, 907 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.78 (s, 1H, CHO), 7.58 (dd, 
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1H, J = 0.9, 1.8 Hz, 5-H in furan), 7.21 (dd, 1H, J = 1.1, 3.6 Hz, 3-H in furan), 6.54 (m, 
1H, 4-H in furan), 3.30 (dd, 1H, J = 7.8, 17.4 Hz, CH2CO-furanyl), 3.11-3.02 (m, 1H, 
CHCHO), 2.87 (dd, 1H, J = 4.8, 17.4 Hz, CH2CO-furanyl), 1.81-1.72 (m, 1H, 
CH2CH2CH2CH2CH2CH3), 1.59-1.47 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.38-1.27 (m, 
8H, CH2CH2CH2CH2CH2CH3), 0.89 (t, 3H, J = 6.9 Hz, CH3);  13C NMR (75 MHz, 
CDCl3) δ 203.32, 187.20, 152.46, 146.40, 117.16, 112.33, 46.55, 37.07, 31.56, 29.29, 
28.71, 26.93, 22.53, 14.03; HRMS (EI+) exact mass calculated for [M]+ (C14H20O3) 
requires m/z 236.1412, found m/z 236.1418; [α]D = +70.1 (c = 1.03, CH2Cl2). 
 
H
O
hexyl O
S
 
(R)-2-(2-oxo-2-(thiophen-2-yl)ethyl)octanal (Table 2, entry 3):  Prepared 
according to the general procedure from octanal (32.8 mg, 0.256 mmol) and tert-
butyldimethyl(1-(thiophen-2-yl)vinyloxy)silane (92.3 mg, 0.384 mmol) at -50 oC 
reaction temperature to provide the title compound as a pale yellow oil (45.2 mg, 70% 
yield, 93% ee) after purification by flash column chromatography on Davisil (3% 
ether/pentane). The enantiomeric ratio was determined by SFC analysis Chiralcel AD-H 
(25 cm × 0.46 cm) column (5% to 50% MeOH, linear gradient, 100 bar, 35°C oven, 
flow = 4.0 mL/min) after oxidation of product to acid derivative; (S) isomer tr = 5.06 
min and (R) isomer tr = 5.43 min.  IR (film) 3092, 2928, 2857, 2719, 1725, 1663, 1518, 
1459, 1416, 1357, 1235, 1058, 939 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.79 (d, 1H, J = 
0.6 Hz, CHO), 7.75 (dd, 1H, J = 0.9, 4.1 Hz, 5-H in thiophene), 7.64 (dd, 1H, J = 0.9, 
4.9 Hz, 3-H in thiophene), 7.14 (dd, 1H, J = 3.6, 5.1 Hz, 4-H in thiophene), 3.41 (dd, 
1H, J = 7.5, 17.1 Hz, CH2CO-thiophenyl), 3.13-3.04 (m, 1H, CHCHO), 2.98 (dd, 1H, J 
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= 4.9, 17.2 Hz, CH2CO-thiophenyl), 1.83-1.73 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.57-
1.48 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.37-1.28 (m, 8H, CH2CH2CH2CH2CH2CH3), 
0.89 (t, 3H, J = 6.9 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 203.37, 190.89, 143.72, 
133.81, 132.07, 128.14, 46.87, 38.04, 31.56, 29.30, 28.78, 26.98, 22.54, 14.03; HRMS 
(EI+) exact mass calculated for [M]+ (C14H20O2S) requires m/z 252.1184, found m/z 
252.1173; [α]D = +69.7 (c = 0.45, CH2Cl2). 
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(R)-2-(2-oxobut-3-enyl)octanal (Table 2, entry 4):  Prepared according to the 
general procedure from octanal (32.8 mg, 0.256 mmol) and (1,3-butadien-2-
yloxy)trimethylsilane (72.8 mg, 0.512 mmol) to provide the title compound as a 
colorless oil (30.6 mg, 61% yield, 90% ee) after purification by flash column 
chromatography on Davisil (3% ether/pentane).  The enantiomeric ratio was 
determined by SFC analysis Chiralcel AD-H (25 cm × 0.46 cm) column (5% to 50% 
MeOH, linear gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); (S) isomer tr = 2.52 
min and (R) isomer tr = 2.99 min.  IR (film) 2929, 2858, 2718, 1727, 1702, 1683, 1616, 
1467, 1402, 1245, 1198, 1084, 987 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.74 (d, 1H, J = 
0.9 Hz, CHO), 6.43-6.22 (m, 2H, CH=CH2), 5.87 (dd, 1H, J = 1.4, 10.2 Hz, CH=CH2), 
3.08 (dd, 1H, J = 8.0, 17.4 Hz, CH2COCH), 3.01-2.95 (m, 1H, CHCHO), 2.63 (dd, 1H, 
J = 4.4, 17.4 Hz, CH2COCH), 1.76-1.69 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.50-1.42 
(m, 1H, CH2CH2CH2CH2CH2CH3), 1.31-1.27 (m, 8H, CH2CH2CH2CH2CH2CH3), 0.88 
(t, 3H, J = 6.9 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 203.46, 198.47, 136.25, 
128.66, 46.56, 38.28, 31.56, 29.29, 28.71, 26.96, 22.54, 14.03; HRMS (EI+) exact mass 
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calculated for [M]+ (C12H20O2) requires m/z 196.1463, found m/z 196.1471; [α]D = +83.7 
(c = 0.82, CH2Cl2). 
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(R)-2-(2-cyclohexenyl-2-oxoethyl)octanal (Table 2, entry 5):  Prepared 
according to the general procedure from octanal (32.8 mg, 0.256 mmol) and tert-
butyl(1-cyclohexenylvinyloxy)dimethylsilane (91.6 mg, 0.384 mmol) to provide the 
title compound as a colorless oil (45.5 mg, 71% yield, 92% ee) after purification by 
flash column chromatography on Davisil (3% ether/pentane).  The enantiomeric ratio 
was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) column (5% 
MeCN, 100 bar, 35°C oven, flow = 4.0 mL/min); (S) isomer tr = 1.73 min and (R) 
isomer tr = 1.79 min.  IR (film) 2930, 2859, 2715, 1726, 1666, 1638, 1458, 1423, 1389, 
1344, 1270, 1196, 1136, 1081, 995 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.75 (d, 1H, J = 
1.2 Hz, CHO), 6.96-6.93 (m, 1H, C=CHCH2), 3.11 (dd, 1H, J = 8.3, 17.1 Hz, CH2COC), 
2.95-2.90 (m, 1H, CHCHO), 2.70 (dd, 1H, J = 4.8, 17.1 Hz, CH2COC), 2.28-2.21 (m, 
4H, H in cyclohexenyl), 1.74-1.65 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.64-1.56 (m, 4H, 
H in cyclohexenyl), 1.47-1.34 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.34-1.21 (m, 8H, 
CH2CH2CH2CH2CH2CH3), 0.88 (t, 3H, J = 6.8 Hz, CH3);  13C NMR (75 MHz, CDCl3) 
δ 204.15, 198.86, 140.43, 139.0, 46.79, 36.35, 31.58, 29.32, 28.88, 27.06, 26.01, 23.01, 
22.55, 21.87, 21.49, 14.04; HRMS (EI+) exact mass calculated for [M]+ (C16H26O2) 
requires m/z 250.1933, found m/z 250.1941; [α]D = +53.0 (c = 0.45, CH2Cl2). 
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(R)-2-hexyl-7,7-dimethyl-6-oxooct-4-enal (Table 2, entry 6):  Prepared 
according to the general procedure from octanal (32.8 mg, 0.256 mmol) and (Z)-tert-
butyl(2,2-dimethylhexa-3,5-dien-3-yloxy)dimethylsilane (92.3 mg, 0.384 mmol) to 
provide the title compound as a colorless oil (47.9 mg, 74% yield, 96% ee) after 
purification by flash column chromatography on Davisil (3% ether/pentane).  The 
enantiomeric ratio was determined by SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) 
column (5% MeCN, 100 bar, 35°C oven, flow = 4.0 mL/min); (S) isomer tr = 1.05 min 
and (R) isomer tr = 1.18 min.  IR (film) 2930, 2859, 2716, 1726, 1690, 1626, 1477, 
1466, 1395, 1366, 1280, 1200, 1081, 995 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.63 (d, 
1H, J = 2.1 Hz, CHO), 6.88-6.79 (m, 1H, CH2CH=CHCO), 6.55 (dt, 1H, J = 1.2, 15.0 
Hz, CH2CH=CHCO), 2.61-2.42 (m, 2H, CH2CH=CHCO & CHCHO), 2.38-2.27 (m, 
1H, CH2CH=CHCO), 1.68-1.63 (m, 1H, CH2CH2CH2CH2CH2CH3), 1.54-1.42 (m, 1H, 
CH2CH2CH2CH2CH2CH3), 1.28-1.16 (m, 8H, CH2CH2CH2CH2CH2CH3), 1.14 (s, 9H, 
C(CH3)3), 0.88 (t, 3H, J = 6.9 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 203.69, 199.58, 
143.29, 126.32, 50.62, 42.87, 31.56, 31.26, 29.28, 28.50, 26.56, 26.08, 22.53, 14.02; 
HRMS (EI+) exact mass calculated for [M]+ (C16H28O2) requires m/z 252.2089, found 
m/z 252.2095; [α]D = +18.5 (c = 0.74, CH2Cl2). 
 
H
Me
O
hexyl O  
(R)-2-(2-oxopropyl)octanal (Table 2, entry 7):  Prepared according to the 
general procedure from octanal (32.8 mg, 0.256 mmol) and tert-butyldiphenyl(prop-1
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en-2-yloxy)silane (152 mg, 0.512 mmol) to provide the title compound as a colorless oil 
(31.8 mg, 67% yield, 86% ee) after purification by flash column chromatography on 
Davisil (5% ether/pentane).  The enantiomeric ratio was determined by GLC using a 
Chirasil-Dex-CB (30 m × 0.25 mm) column (130 oC isotherm for 30 minutes, 1 
mL/min); (S) isomer tr = 13.10 min and (R) isomer tr = 14.02 min.  IR (film) 2929, 
2858, 2717, 1719, 1466, 1408, 1364, 1166, 963 cm-1; 1H NMR (300 MHz, CDCl3) δ 
9.70 (s, 1H, CHO), 2.92-2.84 (m, 2H, CH2COMe & CHCHO), 2.45 (dd, 1H, J = 7.65, 
20.7 Hz, CH2COMe), 2.19 (s, 3H, COCH3), 1.68-1.47 (m, 2H, 
CH2CH2CH2CH2CH2CH3), 1.30-1.26 (m, 8H, CH2CH2CH2CH2CH2CH3), 0.89 (t, 3H, J 
= 6.9 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 206.73, 203.51, 46.74, 42.11, 31.56, 
30.12, 29.28, 28.56, 26.95, 22.53, 14.03; HRMS (EI+) exact mass calculated for [M]+ 
(C11H20O2) requires m/z 184.1463, found m/z 184.1458; [α]D = +76.6 (c = 0.96, CH2Cl2). 
 
H
tBu
O
hexyl O  
(R)-2-(3,3-dimethyl-2-oxobutyl)octanal (Table 2, entry 8):  Prepared 
according to the general procedure from octanal (32.8 mg, 0.256 mmol) and tert-
butyl(3,3-dimethylbut-1-en-2-yloxy)dimethylsilane (109.8 mg, 0.512 mmol) to provide 
the title compound as a colorless oil (31.8 mg, 55% yield, 92% ee) after purification by 
flash column chromatography on Davisil (3% ether/pentane).  The enantiomeric ratio 
was determined by GLC using a Chirasil-Dex-CB (30 m × 0.25 mm) column (130 oC 
isotherm for 30 minutes, 1 mL/min); (S) isomer tr = 29.05 min and (R) isomer tr = 29.44 
min.  IR (film) 2958, 2929, 2859, 2715, 1725, 1702, 1478, 1459, 1396, 1365, 1068, 
1002 cm-1; 1H NMR (300 MHz, CDCl3) δ 9.73 (s, 1H, CHO), 2.98-2.86 (m, 2H, 
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CH2CO-t-Bu & CHCHO), 2.55 (dd, 1H, J = 3.9, 17.1 Hz, CH2CO-t-Bu), 1.70-1.58 (m, 
2H, CH2CH2CH2CH2CH2CH3), 1.30-1.22 (m, 8H, CH2CH2CH2CH2CH2CH3), 1.16 (s, 
9H, C(CH3)3), 0.88 (t, 3H, J = 6.6 Hz, CH3);  13C NMR (75 MHz, CDCl3) δ 214.07, 
203.88, 46.58, 44.01, 36.02, 31.58, 29.32, 28.74, 27.07, 26.49, 22.54, 14.03; HRMS 
(EI+) exact mass calculated for [M+H]+ (C14H27O2) requires m/z 227.2011, found m/z 
227.2022; [α]D = +67.6 (c = 0.26, CH2Cl2). 
 
H
O
Ph
O
3
Et  
(R)-2-(2-oxo-2-phenyl ethyl)-dec-7-enal (eq. 6): A solution of the 
trifluoromethanesulfonic acid salt of (2S, 5S)-2-tert-butyl-5-benzyl-3-methyl-
imidazolidin-4-one (18.0 mg, 0.05 mmol) in acetone (4 mL, 0.0625 M) is prepared in a 
scintillation vial equipped with a magnetic stir bar at -78 oC under argon.  In this order, 
cis-7-decenal (39.5 mg, 0.256 mmol), trimethyl-(1-phenyl-vinyloxy)-silane (96.6 mg, 
0.512 mmol), water (18.0 mg, 0.512 mmol), CAN (274 mg, 0.512 mmol), and 2,6-di-
tert-butyl pyridine (98.0 mg, 0.512 mmol) are added to this mixture. After purging the 
solution with argon for 1 minute, this mixture is warmed to -20 oC and stirred at 
constant temperature for 24 hours until no further reaction progression is observed. The 
cold reaction is poured into diethyl ether and filtered through davisil, washed with ether 
and concentrated in vacuo. The resulting residue is purified by flash column 
chromatography on Davisil (3% ether/pentane) to provide the title compound as a 
colorless oil (55 mg, 79% yield, 91% ee).  The enantiomeric ratio was determined by 
SFC analysis Chiralcel OJ-H (25 cm × 0.46 cm) column (5% to 9.5% CH3CN, linear 
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gradient, 100 bar, 35°C oven, flow = 4.0 mL/min); tr = 2.59 min and 2.91 min.  IR 
(film) 3583, 2961, 2931, 1857, 1725, 1684, 1598, 1449 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 9.82 (d, 1H, J = 0.9 Hz, CHO), 7.99-7.95 (m, 2H, aryl H), 7.60-7.55 (m, 1H, 
aryl H), 7.49-7.44 (m, 2H, aryl H), 5.41-5.24 (m, 2H, CH=CH), 3.47 (dd, 1H, J = 7.5, 
17.4 Hz, CH2COPh), 3.14-2.98 (m, 2H, CH2COPh & CHCHO), 2.07-1.97 (m, 4H, 
CH2CH=CHCH2CH3), 1.86-1.74 (m, 1H, CH2CHCHO), 1.60-1.49 (m, 1H, 
CH2CHCHO), 1.43-1.37 (m, 4H, CH2CH2CH2CH=CHCH2CH3), 0.95 (t, 3H, J = 7.2 
Hz, CH=CHCH2CH3);  13C NMR (75 MHz, CDCl3) δ 203.53, 197.94, 136.51, 133.27, 
132.02, 128.60, 128.54, 128.05, 46.69, 37.61, 29.68, 28.73, 26.74, 26.65, 20.49, 14.33; 
HRMS (EI+) exact mass calculated for [M]+ (C18H24O2) requires m/z 272.1789, found 
m/z 272.1776; [α]D= +60.0 (c = 0.63, CHCl3). 
 
Determination of absolute configuration by chemical correlation:  
 
H
Ph
O
hexyl O
H
Ph
O
hexyl
O3,CH2Cl2, -78 
oC
 
(R)-2-(2-oxo-2-phenylethyl)octanal (Table 1, entry 1) was synthesized from (R)-
2-(2-phenylallyl)octanal5 by ozonolysis: To a 50 mL round-bottom-flask containing 
(R)-2-(2-phenylallyl)octanal5 (20 mg, 0.082 mmol) was dissolved in dichloromethane 
(20 mL). O3 was purged through the reaction solution at -78 oC for 30 min, at which 
point dimethylsulfide (2 mL) was added to quench the reaction. The resulting mixture 
was allowed to warm to room temperature while vigorous stirring (30 min). After 
concentration of reaction mixture in vacuo, purification by forced flow chromatography 
                                                      
5 Beeson, T. D.; Mastracchio, A.; Hong, J.-B.; Ashton, K.; MacMillan, D. W. C. Science 2007, 
316, 582-585. 
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on Iatrobeads (10-15% Et2O/pentane) afforded (R)-2-(2-oxo-2-phenylethyl)octanal 
(Table 1, entry 1) as a colorless oil (6 mg, 30% yield, 90% ee). The observed optical 
rotation ([α]D= +60.4 (c = 0.53, CHCl3)) displayed the sign of rotation, which is 
consistent with the designated (R)-configuration for 2-(2-oxo-2-phenylethyl)octanal 
([α]D= +63.9 (c = 1.30, CHCl3) for 90% ee). 
 
H
Me
O
hexyl O
H
O
hexyl
PdCl2, CuCl2
DME/H2O (9/1)  
(R)-2-(2-oxopropyl)octanal (Table 2, entry 7) was synthesized from (R)-2-
allyloctanal5,6 by Wacker oxidation7: To a 50 mL round-bottom-flask containing (R)-2-
allyloctanal (50 mg, 0.299 mmol) and dissolved in DME/H2O (9:1) was added PdCl2 
(5.3 mg, 0.03 mmol) and CuCl2 (4.0 mg, 0.03 mmol) in one portion at room temperature. 
The reaction mixture was stirred under an oxygen atmosphere for 30 min, followed by 
aqueous extractive work-up with Et2O. The organic layers were combined, dried and 
concentrated in vacuo. The resulting residue was purified by forced flow 
chromatography on Iatrobeads (30% Et2O/pentane) afforded (R)-2-(2-oxopropyl)octanal 
(Table 2, entry 7) as a colorless oil (20.6 mg, 37% yield, 83% ee). The observed optical 
rotation ([α]D= +82.6 (c = 0.89, CH2Cl2)) displayed the sign of rotation, which is 
consistent with the designated (R)-configuration for 2-(2-oxopropyl)octanal ([α]D= 
+76.6 (c = 0.96, CH2Cl2) for 86% ee). 
                                                      
6 Hasegawa, T.; Yamamoto, H. Bull. Chem. Soc. Jpn. 2000, 73, 423. 
7 Kulkarni, M. G.; Davawala, S. I.; Doke, A. K.; Pendharkar, D. S. Synthesis 2004, 2919-2926. 
